Related Experiment Videos
[PTH/PTHrP receptor and pseudohypoparathyroidism]
1Niigata University of Health and Welfare.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|February 23, 2002
Summary
Parathyroid hormone (PTH) resistance is linked to GNAS1 gene mutations, not the PTH/PTHrP receptor. Pseudohypoparathyroidism (PsH) involves Gs alpha protein dysfunction, with imprinting potentially explaining disease variations.
Area of Science:
- Endocrinology and Molecular Genetics
- G protein-coupled receptor signaling pathways
- Skeletal dysplasia genetics
Context:
- The parathyroid hormone (PTH)/PTH-related peptide (PTHrP) receptor, a G protein-coupled receptor, mediates PTH and PTHrP actions.
- Blomstrand chondrodystrophy, a lethal disorder, results from homozygous inactivating mutations in the PTH/PTHrP receptor.
- Pseudohypoparathyroidism (PsH) is characterized by hypoparathyroidism and PTH resistance, but receptor mutations are absent.
Purpose:
- To investigate the genetic basis of PTH resistance in Pseudohypoparathyroidism (PsH).
- To differentiate the genetic causes of Blomstrand chondrodystrophy and PsH.
- To explore the role of GNAS1 gene and Gs alpha protein in PsH pathogenesis.
Summary:
- Inactivating mutations in the PTH/PTHrP receptor are not found in PsH patients.
- Heterozygous inactivating mutations in the GNAS1 gene encoding Gs alpha protein are identified in PsH type Ia.
- Abnormalities in GNAS1 outside coding exons are suggested for PsH type Ib.
- Tissue- or cell-specific imprinting of Gs alpha is implicated in PsH heredity and phenotypic variation.
Impact:
- Clarifies the genetic etiology of Pseudohypoparathyroidism, distinguishing it from receptor-mediated disorders.
- Highlights the critical role of Gs alpha protein and GNAS1 imprinting in endocrine signaling and disease.
- Provides a foundation for understanding the molecular mechanisms underlying PTH resistance and related conditions.